Thiazolidinedione therapy for nonalcoholic steatohepatitis: go, stop, or proceed with caution?
Hepatology
.
2010 Feb;51(2):366-9.
doi: 10.1002/hep.23473.
Author
Stephen A Harrison
PMID:
20101743
DOI:
10.1002/hep.23473
No abstract available
Publication types
Editorial
Comment
MeSH terms
Fatty Liver / drug therapy*
Humans
Hypoglycemic Agents / therapeutic use*
Thiazolidinediones / administration & dosage*
Substances
Hypoglycemic Agents
Thiazolidinediones
2,4-thiazolidinedione